Watchlist

Watchlist
Allergan plc. (AGN)
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering
Content Analysis of coverage: REGN Stocks in the news: LLY, SNY, BLUE Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Trade Idea of the Day (for TPT subscribers only) Subscriber Questions & An…
Biotech Analysis Central Pharma News: AbbVie And Roche Stellar Data, Aduro Pulls The Cord, Allergan's Bargain Bin Buy
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Abbvie and Roche Put Out Amazing Phase 3 Leukemia Data News: Recently, Abbvie ( ABBV ) and Roche ( RHHBY ) announced positive phase 3 data in pat…
Aegon Supervisory Board Chairman Rob Routs to Step Down at Next AGM
THE HAGUE, Netherlands , December 14, 2017 /PRNewswire/ -- Supervisory Board has elected William Connelly as its next Chairman Aegon today announces that Mr. Robert J. Routs, Chairman of its Supervisory Board, has decided to step down at the next Annual General …
Aegon Supervisory Board Chairman Rob Routs to Step Down at Next AGM
THE HAGUE, Netherlands , December 14, 2017 /PRNewswire/ -- Supervisory Board has elected William Connelly as its next Chairman Aegon today announces that Mr. Robert J. Routs, Chairman of its Supervisory Board, has decided to step down at the next Annual General Meeting of S…
Aegon Supervisory Board Chairman Rob Routs to Step Down at Next AGM
THE HAGUE, Netherlands , December 14, 2017 /PRNewswire/ -- Supervisory Board has elected William Connelly as its next Chairman Aegon today announces that Mr. Robert J. Routs, Chairman of its Supervisory Board, has decided to step down at the next Annual General Meeting of S…
Conatus: Likely To Dash Ahead Of NASH Data
Background Commonly referred to as "the next hepatitis C", nonalcoholic steatohepatitis ((NASH)), is a type of nonalcoholic fatty liver disease (NAFLD). Unlike most cases of NAFLD (alcohol toxicity and hepatitis C infection), the cause of NASH is relatively unknown. It's estimated between …
Top 10 Net Payout Yields For December 2017
This article is a continuation of a monthly series highlighting the top net payout yield (NPY) stocks that was started back in June 2012 and explained in August 2012 . The series highlights the best stocks for the upcoming month utilized in part to make investment decisions for the IB Asse…
Your Daily Pharma Scoop: Omeros Potential, Portola's Setback, Proteostasis Soars
Content Analysis of coverage Stocks in the news Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar TPT subscribers only Trade Idea of the Day Subscriber Questions & Answers Catalyst Ru…
Ease Those Frown Lines: Revance's Impact On Allergan Overblown
Whoa, whoa, let's slow those horses down a bit. In the past few week we've seen articles about the risks Revance's ( RVNC ) RT-002 poses for Allergan's ( AGN ) Botox; ostensibly because Revance's neurotoxin could have a longer-acting duration. Have we been critical of the company and its …
Allergan Receives FDA Clearance For the CoolSculpting® Treatment To Improve Appearance Of Lax Tissue In The Double Chin
DUBLIN , Dec. 12, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the CoolSculpting treatment is the first and only non-surgical fat reduction technology to be FDA-cleared for improved appearance of lax tissue in conjunction with submental fat, or double chin, t…
Is The Valeant, Ackman Insider Trading Case Finally Here?
Pershing Square's Bill Ackman. Source: Bloomberg. According to Bloomberg, Valeant ( VRX ) and Bill Ackman of Pershing Square ( PSHZF ) could face a jury trial for insider trading in Allergan ( AGN ) shares: Activist investor Bill Ackman and his estranged former collaborator in a 201…
Allergan plc. (AGN)